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PLATES 43 ~O 45 (Received for publication, June 21, 1956) This paper is concerned with conditions required for the growth of a transplanted benign m a m m a r y tumor of the rat and with the identification of hormones which accelerate its growth in animals deprived of the ovaries and the hypophysis. The mammary glands of these rats are atrophic y e t grow in the presence of certain hormones and so permit the study in parallel of the growth of the tumor and of the breast of its host. Do these closely related tissues respond identically to hormonal stimulators of growth?
Fibroadenomas of the mammary gland of the rat are neoplasms which have long been known. They have large interest because of typical distinctive peculiarities to be described. They have certain functional characteristics of their tissue of origin so that their growth is profoundly influenced by the administration or withdrawal of appropriate hormones; in these ways the tumors resemble certain cancers of the human breast. The fibroadenoma is readily transplantable to other rats where, under favorable conditions, it grows to large size in a few months. Much difficulty has been encountered in earlier work in the standardization of the growth of this tumor, and it has led to contradictory statements concerning the effects of hormones upon its growth. In the present experiments some progress was made in the conduct of the experiments so that the effect of endocrine modifications on the growth of the tumor has become reproducible, permitting the recognition of growth-promoting agents.
The effect of hormones on established cancers of the breast have been learned exclusively from studies of the disease in man. It is known that some of the mammary cancers of the human being are dependent on hormones since they regress following removal of the ovaries (1), the adrenal glands (2) , or the hypophysis (3, 4) . The hormones which are critical in the maintenance and propagation of these hormonedependent neoplasms have not been identified. In contrast to such human cancers, the mammary carcinomas of animals usually are so undifferentiated that they have lost the responsiveness to hormonal changes which is characteristic of the mammary gland itself, hence the need for a more reactive tumor for experimental purposes. It will be shown that the benign tumor employed in the present experiments fulfills many of the laboratory requirements and so constitutes a useful experimental model.
Mammary fibroadenoma develops in nearly 50 per cent of female rats of the SpragueDawley strain (5) . It seldom arises before the age of 18 months (6) and has not been observed in males.
Mammary fibroadenoma of the rat can undergo changes in its structure after hormonal stimulation. Loeb and Fleisher (7) were the first to transplant this tumor to other rats and they discovered that pregnancy stimulated its growth. Heiman (8) confirmed these findings and observed a milky secretion in the tumor in pregnant rats. Emge and Murphy (9) likewise found that during pregnancy the adenomatous element of the tumor underwent hyperplasia and that it secreted milk after parturition. Heiman and Krehbiel (10) were the first workers to discover that ovariectomy retards the growth of the tumor.
In earlier work the effects of hormones on the growth of the fibroadenoma have been measured in 2 ways: (a) the percentage of transplants which grew; (b) the time required for the tumor to attain sizes which were arbitrarily selected (12) .
In normal adult females the incidence of "takes" has ranged from 42.7 to 75 per cent of the animals (10) (11) . These values are considerably lower than those to be reported in the present paper. The number of "takes" is greater in normal females than in gonadectomized rats of either sex or adult males (10) (11) (12) .
In addition to calculating the percentage of "takes," Millar and Noble (12) measured the diameters of the tumor and determined thereby the "latent" and "growth" periods of the tumor; they noted an inconsistency of response for all of these criteria.
It has been reported that relatively small amounts (1 to 10 ~g. daily) of estrogenic substances have no effect on the tumor in female rats. The estrogens employed were estrone (13, 14) , diethylstilbestrol (15) , and estradiol (15) . Mohs (11) , on the contrary, stated that estrone increased the number of successful transplants. Large doses of diethylstilbestrol (100 to 200 /~g. daily) caused retardation or arrest of tumor growth (15) ; this inhibition of growth was not related to the decreased intake of food induced by estrogenic substances since the growth rate of the tumor was not depressed by underfeeding (16) .
It has been stated that progesterone in small amounts retarded the growth of the tumor (17) while in larger dosage it exerted no effect (15) .
Crude extracts of the pituitary accelerated the growth of the tumor, but a refined preparation of growth hormone did not alter its growth rate (15) . When chorionic gonadotrophin was injected with estrone in gonadectomized rats the growth rate of the tumor was enhanced but neither hormone was effective when administered separately (10) .
Methods
The mammary fibroadenoma used in the present experiments had arisen in our laboratory in a female rat which had been incompletely hypophysectomized at age 25 days. The tumor was first observed in the rat at age 554 days. It was transplanted into albino rats of the Sprague-Dawley strain which were obtained from the dealer at age 42 days; they were kept thereafter under controlled env/ronmental conditions (18) . All the rats were fed a commerlcal ration except those which were hypophysectomized and these received a high protein synthetic diet (19) . Adrenalectomized rats were maintained on 0.9 per cent sodium chloride drinking fluid without supplemental steroids.
The experiments were based on 17 series of rats each consisting of 106 animals. In each series, 16 rats were kept intact as controls and the others (9 in each group) were subjected to hypophysectomy, ovariectomy, or adrenalectomy at age 42 to 44 days. Hysterectomy was performed in rats which were injected with large dosages of estrogenic compounds. All of the surgical operations and the transplantations of tumor were performed under ether anesthesia.
The tumor was transplanted to recipients at age 51 days. The donor in each case was an intact adult female bearing a large actively growing tumor. After removal from the donor the tumor was sliced and oval fragments were cut from the slices with a surgical punch. Four pieces of tumor were implanted subcutaneously in each inguinal and axillary region through a small incision in the epigastrium. The implants measured about 3 X 2 X 2 mm. and weighed about 40 rag. Every tenth fragment was weighed and the standard deviation of "these weights was calculated. Many of the rats received steroids. I These compounds were dissolved in ethyl alcohol which was diluted with sesame oil to make the final alcoholic concentration 10 per cent. The solution (0.2 ml.) was injected subcutaneously for 6 days each week. Protein hormones were dissolved in a solution of 2 per cent sodium bicarbonate. Throughout this paper dosage refers to the amount administered each day. Each of the experiments described in this paper was repeated on at least 2 separate occasions.
At necropsy the tumors, uteri, and the inguinal mammary glands were weighed on a precision balance. Histological preparations of these tissues and of the vagina were stained with hematoxylin and eosin. The tumors and the mammary glands were placed in a large volume of ice cold acetone which was kept in a refrigerator for 1 day. The content of alkaline phosphatase and the site of this enzyme were then determined.
After evaporation of acetone in an evacuated desiccator at room temperature the tissues were homogenized and the alkaline phosphatase was determined by the method of King and Armstrong (20) ; the results are expressed in the units of these workers.
The site of alkaline phosphatase activity in the mammary gland and the tumor was determined by the method of Gomori (21) . The mammary glands were pressed firmly between sheets of filter paper to express fat; thin equatorial slices of the tumor were cut with a razor. The tissues were then incubated for 4 hours in calcium chloride and sodium fl-glycerophosphate before treatment with cobalt acetate (21) . They were dehydrated in alcohol and acetone and rendered more transparent by immersion in dioxane and, later, methyl salicylate. They were then mounted between 2 sheets of acrylic plastic, ~ I ram. in thickness, and cemented together with catalyzed liquid plastic.
RESULTS
Ten days after transplantation, the grafts consisted of a crescentic rim of surviving ceils surrounding a dead center which always contained a small area of calcification. At 50 days it was found that some of the grafts had not The sheets of acrylic plastic, known as plexiglas, were purchased from Rohm& Haas Co., Philadelphia. The catalyst was ~-butyl hydroperoxide; the liquid plastic used, selectron, was obtained from Pittsburgh Plate Glass Co., Pittsburgh. some 3 to 6 months after transplantation. Necrosis was very rare and metastases were never observed. In an hypophysectomized rat the adenomatous component of one of the tumors changed to a carcinoma 20 days after transplantation; no sarcomas or pure fibromas were detected. The transplants did not grow unless epithelial cells were present.
In intact rats the tumor consisted of a collection of spheroids with an encLrcling network of capillaries. In normal female rats each spheroid consisted of a canal system of ducts ( Fig. 1) surrounded by fibroma cells.
The tumor contains considerable quantities of alkaline phosphatase which is present both in the epithelial cells and in the capillaries (Figs. 2, 3) ; this network of capillaries was far more extensive in rapidly growing tumors (Fig. 4 ) than in those whose growth rate was slower (Fig. 2 ). In the mammary gland this enzyme was demonstrated in the capillaries merely in small amounts ( Fig. 5 ) and the chief concentration was in the epithelial cells.
In 103 normal adult female rats the implants grew in 98 animals (95.1 per cent takes) in a consecutive series of transplantations; tumors developed in each of the last 60 rats implanted. The weight of all of the surviving grafts
TABLE I Effect of Remeoal o/Endocrine Glands on Growth of Fibroadenoma and the Alkaline Phosphatase
Content oJ the Inguinal Mammary Gland There were 9 rats in each group. Necropsy was performed 50 days after transplanting except in 1 group of hypophysectomized rats. A indicates the gain in body weight. in a typical series is shown in Text- Fig. I . Not all the transplants grew in every rat; neither did all of them grow to the same size at an identical rate. In intact adult females autopsied at intervals of 10 days it was found that the mean of the weights of the tumors increased at a logarithmic rate (Text- Fig.  I ). There was no latent period of growth. The logarithmic rate of growth was apparent in each of the 4 series of experiments of this kind.
Effect of Removal of Endocrine Glands
The extirpation of endocrine glands exerted a profound effect on the growth of mammary fibroadenoma (Table I) . Whilst the tumor grows well in intact adult females, ovariectomy resulted in a decrease in size and the removal of the adrenals in addition to the ovaries caused an additional diminution. For 50 days the content of alkaline phosphatase of the mammary glands ran in parallel to the effects of the surgical procedures on tumor weight. In intact rats at 50 days the epithelial cells of the tumor were relatively larger (Fig. 6) and there was more fibromatous stroma than in tumors growing in the ovariectomized females (Fig. 7) .
The tumor grew slowly in hypophysectomized rats for about 70 days when a considerable increase in its growth rate occurred. At 50 days, during the period of indolent growth, the tumors of hypophysectomized (Fig. 8) and ovariectomized rats (Fig. 7) were cytologically similar; the epithelial cells were small and the stroma was sparse. At 90 days, when the tumor was growing rapidly it resembled histologically (Fig. 9 ) the cells of tumors from intact adult females (Fig. 6 ). There was no change in body weight during the period of accelerated growth and, further, the vagina and uterus remained in the profoundly atrophic state of hypophysectomized rats which did not bear the tumor; these findings constitute evidence that the tumor, during its period of active growth, does not secrete significant amounts of growth or steroid hormones.
Effects of Estrogenic Phenols.--Five phenolic estrogens were administered to ovariectomized rats in amounts which induced keratinization of the vagina. Each of these phenols exerted biphasic effects on the growth of the fibroadenoma. With progressive increments of dosage there was first an augmentation of size of the tumor until a growth peak (Text- fig. 2 ) was achieved with optimal amounts of the compound and then there was a profound decrease in size of the tumor when these quantities were exceeded.
Here are the amounts of phenolic estrogens which induced optimal tumor growth: estradiol-17/3, 0.1 gg.; estrone, 1 /~g.; estriol, 10 to 20 gg.; estradiol-3,16a, 50 /~g. The tumors of animals injected at these optimal dosage levels were larger than those of their uninjected intact sisters. The cytology was identical in all groups: there was growth of the ducts of the tumor without the formation of alveoli.
The following dosages of estrogenic phenols profoundly depressed the growth of the tumor: estradiol-17]3, 20 gg.; estrone, 50/~g.; estriol, 100 ~g. Diethylstilbestrol (10 rag.) implanted subcutaneously in pellet form caused a similar depression. The tumors in rats so treated were smaller than those of uninjected control rats subjected to hypophysectomy. These tiny tumors contained ducts embedded in fibromatous stroma and many of the ducts contained small quantities of milk. There was no prolactational proliferation. Necrosis was not observed. Rats injected with increasing doses of these compounds suffered the progressive retardation of body growth which is induced by phenolic estrogens (22) .
There were only subtle architectural changes in the mammary glands of ovariectomized rats injected with optimal amounts of phenolic estrogens. These consisted of a slight widening of the ducts, but alveoli did not develop (Fig. 5) . The dilatation of the ducts increased with larger doses of these estrogenic phenols. With the biggest amounts, large cysts filled with milk were seen along the ducts; this effect has been described earlier (23) .
The administration of small amounts of phenolic estrogens caused a progressive rise in the content and concentration (Text- fig. 2 ) of alkaline phosphatase in the mammary gland and this increment was monophasic. The estrogens, even in the largest dosages employed, did not retard growth of the mammary gland. A~rostane Derivati~es.--Several related compounds (Table If) in the adrostane series were injected into ovariectomized rats bearing the transplanted tumor. These steroids have the common property of inducing growth of the ventral prostate of the female rat but their selection was prompted by physiologic differences which these compounds exert in eliciting growth of other target organs.
TUMOR WEIGHT
19-Nor-ethinyl-testosterone reproduced many of the systemic effects of pregnancy and there was a moderate growth of the vestigial prostate. There was gestational mucification of the vagina and intense prolactational proliferation of the epithelium of the breast. The compound elicited growth of the uterus. The rats receiving this compound (Table H) developed the largest tumors encountered in these experiments. The fibroadenoma was characterized by the proliferation of ducts to form lobules; similar changes in the tumor occur in ovariectomized rats injected with estrone and progesterone.
The estrogenic alcohol, 5-androstene-3/~,lT~-diol elicited keratinization of vagina and growth of the uterus but caused only a slight acceleration of growth of the fibroadenoma. The growth of the mammary glands was also slight. 5-Androsten-3/~-ol-17-one did not modify the growth of the tumor.
Three steroids caused striking growth of the prostate and of the mammary glands and elicited vaginal mucification. These compounds were 4-androstene-
TABLE II

Effect of Steroids in the Androstane Series on Growth of Mammary Fibroadenoma in
Ovarieetomized Rats The steroids, 1 rag. daily, were injected for 50 days with 9 rats in each group. A indicates the gain in body weight during the experiment. 3a, 17/3-diol, 4-androstene-3/3,17fl-diol, and testosterone. The nipples became red and considerably enlarged and the ducts became dilated. There was prolactational proliferation of the mammary epithelium which was especially developed in rats injected with 4-androstene-3a,17/3-diol. These compounds did not accelerate the growth of the tumor in ovariectomized rats (Table II) .
Progesterone.--Progesterone, 2 to 4 mg., administered alone to ovariectomized rats, stimulated the growth of the tumor (Table III) but doses of 1 mg. were ineffective. No growth of the mammary gland was detected in these rats and the vaginal epithelium remained in an atrophic state.
Progesterone, 1 to 4 mg., enhanced the growth of the tumor in ovariectomized rats treated simultaneously with either small or large doses of phenolic estrogens as is shown in Table III . The suppression of growth of the tumor, which is brought about by large amounts of phenolic estrogens was partly overcome by simultaneous administration of progesterone, 1 to 4 mg. Both the mammary glands and the fibroadenoma of rats treated with these hormones in combination had the characteristic proliferative effects seen in pregnancy.
Pituitary Proteins.--Certain highly refined hormones isolated from the pituitary were injected into hypophysectomized rats in which the mammary fibroadenoma had been implanted. These proteins were growth hormone, 0.25 to 0.5 rag., lactogenic hormone, 1 rag., and adrenocorticotrophin (ACTH), 4 units. Injected separately none of these hormones accelerated the growth of the tumor (Table IV) . In rats injected with growth or lactogenic hormones the size of the fibroadenomas was identical with that of the tumors of uninjected hypophysectomized control rats.
TABLE III
Effect of Progesterone and Phenol~ Estrogens on Gromth of Mammary Fibroadenoraa in Ovarieetoraized Rats
The steroids were injected for 50 days and there were 9 rats in each group, zX indicates the gain in body weight during the experiment. Tests were made for the potency of these proteins. The increase in body weight (Table IV) showed that the growth hormone was physiologically active. It was known from other experiments that our sample of lactogenic hormone was capable of inducing lactation in the mammary glands of dogs and rats injected earlier with estrone and progesterone. The combined adrenal weight of the rats injected with ACTIt increased to 24 rag. whereas in uninjected hypophysectomized rats the adrenals weighed 8 rag. on average.
Neither estrone 1 #g. nor progesterone 1 mg., injected separately, caused an increase of size of the tumor in hypophysectomized rats. A considerable increase of tumor size ensued when these steroids were injected together. The injection of growth hormone, 0.5 rag., or of lactogenic hormone 1 mg., together with both estrone and progesterone effected an additional, though slight, increase of weight of the tumor.
In hypophysectomized rats, the morphology of the mammary glands was
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unmodified by the injection, separately, of estrone 1/~g. (Fig. 11) , progesterone 1 mg. (Fig. 12) , lactogenic hormone 1 rag. or ACTH 1 or 4 units. The characteristic slender duct system (Fig. 10) of the mammary glands of hypophysectomized rats persisted despite the injection of these hormones. The combination of estrone and progesterone induced slight growth of the mammary gland ( Fig. 13) while growth of the tumor was much stimulated. Growth hormone 0.25 to 0.5 mg., alone or in combination with estrone and progesterone caused proliferation of the ducts with the formation of acini along the mammary tree (Figs. 14 and 15 ).
TABLE IV
Effect of Steroids and Pituitary Hormones on Growth of Mammary Fibroadenoma Sn ttypopkysectomized Rats
The hormones were injected for 50 days and there were 9 rats in each group. A indicates the gain in body weight during the experiment. 
DISCUSSION
Quantitative studies of metabolic activity in the non-pregnant or nonlactating mammary gland of the rat present unusual difficulties. Each breast of the normal adult rat consists of a few delicate tubules which ramify diffusely in a large pad of fat. The determination of the content and concentration of alkaline phosphatase proved to be a useful quantitative indicator of hormonal response by the epithelial cells of the mammary gland. The methods are simple and reproducible. The values were easily correlated with the site of the enzyme as determined histochemically. The principal locus of this enzyme is the epithelial cells; the phosphatase-containing capillaries of the intact mammary gland are few.
A critical test for any proposed chemical method for determining the effects of hormones on growth of the mammary gland is its success in distinguishing between the glands of intact and ovariectomized adult females. The extirpation of certain endocrine glands resulted in great differences in the values of alkaline phosphatase in the breast. The mammary glands of intact females have a significantly higher phosphatase content than those of their ovariectomized sisters whilst the breasts of hypophysectomized rats contain only small amounts of the enzyme. Moreover, phenolic estrogens increase the amount of alkaline phosphatase in the mammary glands of ovariectomized rats. Under hormonal conditions favorable to the growth of the tumor, such as exist in the intact adult female, the incidence of successful transplants of fibroadenoma approaches 100 per cent of the animals and there is no latent period of growth. Some of the grafts die however and the surviving transplanted fragments do not grow at a uniform rate. But the use of multiple transplants permits the accumulation of a considerable number of tumors in a series of 9 rats and, with this the case, the weight of the grafts on the average indicates that the tumor grows at a logarithmic rate. The lack of precision precludes valid deductions drawn from small differences in mean tumor weight. Effects of large magnitude were repeatedly confirmed in repeated experiments; and only these are under discussion.
The most consistent results were obtained when the tumors subjected to experiment were harvested at a time when one of the diameters of the tumors in intact adult females was about 1 cIn. Tumors of this size then weighed about 0.5 to 1 gin.
To ascertain the effects of hormones on the growth of mammary neoplasms through experimentation is it necessary to study a mammary tumor, or is the non-neoplastic mammary gland adequate? It appears that neoplastic cells are required. True, there are similarities in the effects of hormones on the growth of both mammary gland and mammary fibroadenoma, but significant differences of response exist.
To cite some of the similarities, small amounts of estrogenic phenols induce growth both in mammary gland and tumor and large amounts of these substances bring on lactation in each. In both tissues progesterone enhances the growth-promoting properties of estrogenic substances.
The differences of action of hormones on mammary gland and fibroadenoma are many and striking. Yet another important difference between the growth of the tumor and the mammary gland was observed in hypophysectomized rats. Following a period of many weeks wherein growth of the tumor was not apparent, the fibroadenoma increased in size and eventually becomes large, but there is no associated growth in the mammary gland. During the time of quiescence the tumor was atrophic but during active growth it is identical cytologically with fibroadenomas in intact, adult females. Profoundly influenced by the presence of certain steroids in the organism, the tumor acquires the ability to grow actively in hypophysectomized rats wherein the presence of these compounds cannot be detected by biological means. The epithelium of the vagina is a sensitive indicator (18) of the presence of growth-promoting steroids, and its cells remain atrophic.
In hypophysectomized rats estrone and progesterone, injected together, induced growth of the tumor, and growth hormone or lactogenic hormone intensified this growth. None of these hormones administered separately induced growth in these rats. The steroid hormones exerted a greater influence on growth of the tumor than the protein hormones of the pituitary but synergism existed among certain members of these classes of endocrine substances.
The effects of steroids in inciting growth of the tumor could not be correlated with either the amount or the kinds of growth which these compounds evoke in the normal organs of the rat. Mammary fibroadenoma apparently possesses characteristics of hormonal reactivity which are peculiar to itself amongst the endocrine target cells of this species. It was therefore of noteworthy interest to find that all the therapeutic measures now known to retard mammary cancer in clinical practice likewise retard the growth of this benign tumor. It would appear that in its endocrinologic responses the rat tumor resembles these human tumors more closely than it does the mammary gland of the rat.
CONCLUSIONS
A transplanted mammary fibroadenoma was found to grow in 95 per cent of intact adult female rats and the increment of tumor weights was progressive and logarithmic.
The growth of the tumor was retarded by ovariectomy and still more when this was combined with adrenalectomy. In ovariectomized rats the growth of the tumor was stimulated by phenolic estrogens, this increase being enhanced when progesterone was added.
In these responses to hormonal changes the mammary gland and the tumor resembled each other. Yet there are many differences between the growth of the fibroadenoma and that of the mammary gland. In contrast to the progressive growth which occurred in intact adult females there was a prolonged period of indolent growth of transplants in hypophysectomized rats; but after many weeks active growth began and the tumors eventually reached large size. During the period of quiescent growth the tumor was cytologically atrophic but after the growth spurt had started the microscopic appearance of the fibroadenoma resembled that of tumors growing in normal adult females. The mammary gland remained atrophic during both the slow and the accelerated phases of tumor growth, and so too with the other secondary sex expressions.
In hypophysectomized rats estrone and progesterone, when combined, stimulated the growth of the tumor, and this growth was accelerated by the additional administration of lactogenic or growth hormones. None of these hormones, separately, stimulated the growth of the tumor.
In ovariectomized rats other differences were demonstrated between the growth of the mammary gland and the fibroadenoma. Progesterone, injected alone, accelerated the growth of the tumor but not that of the mammary glands. The administration of phenolic estrogens exerted a biphasic effect on the growth of the tumor whilst that on the breast of its hosts was monophasic. With progressively increasing doses of these phenols there occurred primarily an augmentation of the rate of growth of the tumor until a peak was achieved; an increase of the dose above the optimal amount depressed the growth of the tumor. The stage of depression of growth was not observed in the mammary glands of these tumor-bearing rats.
Many steroids which induced gestational changes in the mammary gland accelerated the growth of the tumor. Among these were estrone and progesterone in combination and 17a-ethinyl-19-nor-testosterone administered alone. But gestational changes developed in the mammary gland of rats treated with 4-androstene-3ot, 17fl-diol, without growth of the tumor.
The evidence which we have presented proves that the mammary fibroadenoma tested had some of the functional properties of a normal mammary gland, and neoplastic traits as well. In its response to hormones it had characteristics which set it apart from all other endocrine targets of the rat. FIo. 2. An equatorial slice of mammary fibroadenoma from an intact rat 50 days after transplantation, showing the distribution of alkaline phosphatase in the duct system and the surrounding capillary net. The method of Gomori (21) From an hypophysectomized rat injected with growth hormone, 0.25 rag., estrone 1 ~zg., and progesterone 1 rag. Growth has taken place in the ducts and alveoli are evident. X 90.
